Publication

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)

Related publications (63)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)

Graph Chatbot

Chat with Graph Search

New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis

Optimization of drug combinations using Feedback System Control

Inhibiting Mycobacterium tuberculosis within and without

A streamlined search technology for identification of synergistic drug combinations

4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections

Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter

Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis

Kinetics of Ultrasonic Drug Delivery from Targeted Micelles

Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancer

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects